The Contact Activation System and Ulcerative Colitis
NCT04621006 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 102
Last updated 2025-02-25
Summary
The study aims to describe alterations in the contact activation system during active and inactive ulcerative colitis.
Contact activation system measures are compared in a cross sectional (healthy controls vs. active disease) and longitudinal (active diasese vs. inactive disease) fashion.
Conditions
Interventions
- DIAGNOSTIC_TEST
-
Continuously assessment of disease activity
Continuous measures of disease activity and activity in the contact activation system.
Sponsors & Collaborators
-
UMC Utrecht
collaborator OTHER -
University of Southern Denmark
collaborator OTHER -
Esbjerg Hospital - University Hospital of Southern Denmark
lead OTHER
Principal Investigators
-
Morten L Halling, M.D. · Department of Medical Gastroenterology, University Hospital of Southern Denmark - Esbjerg
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-05-01
- Primary Completion
- 2023-11-30
- Completion
- 2023-11-30
Countries
- Denmark
Study Locations
More Related Trials
-
Gastrointestinal Motility in Severe Ulcerative Colitis Obtained by Motilis-3D-transit
NCT01745029 ·Status: UNKNOWN
-
Feasibility of a Multimodal Intervention Program to Optimize Treatment Outcomes in Ulcerative Colitis
NCT05743153 ·Status: UNKNOWN ·Phase: NA
-
Gastrointestinal Transit Times and Motility in Severe Ulcerative Colitis Obtained by Motilis-3D-transit
NCT01752361 ·Status: UNKNOWN
-
Effects of Gluten Free Diet in Ulcerative Colitis
NCT06249763 ·Status: COMPLETED ·Phase: NA
-
Scintigraphic Evaluation of IPAA Function in Patients With Ulcerative Colitis
NCT02110862 ·Status: COMPLETED
-
The Validity of Novel Non-invasive Inflammatory Markers for Monitoring of Patients With Ulcerative Colitis
NCT04670250 ·Status: UNKNOWN
-
Upper Endoscopy in Ulcerative Colitis Patients in Assiut University
NCT06092593 ·Status: NOT_YET_RECRUITING
-
Disease Course in an IBD Cohort in the Era of Biological Treatment
NCT01468090 ·Status: COMPLETED
-
Correlation of Infliximab Levels With Outcomes in Ulcerative Colitis
NCT02438410 ·Status: COMPLETED
-
MIcroorganisms as Triggers in Acute Severe Ulcerative Colitis and Their Influence on Medical Therapy Efficacy: a Multi-omics Pilot Approach.
NCT04272307 ·Status: UNKNOWN
-
AI-driven Narrow-band Imaging Score for Disease Assessment and Outcome Prediction in Ulcerative Colitis
NCT06709209 ·Status: RECRUITING
-
A Study of Abatacept in Patients With Active Ulcerative Colitis
NCT00410410 ·Status: COMPLETED ·Phase: PHASE3
-
Hematological Indices and Fecal Calprotectin Predict Histological Remission in Ulcerative Colitis
NCT04818788 ·Status: UNKNOWN
-
Diet Intervention Treatment for Active Ulcerative Colitis
NCT04121806 ·Status: RECRUITING ·Phase: NA
-
Multispectral Optoacoustic Tomography (MSOT) for the Evaluation of Disease Activity in Inflammatory Bowel Diseases (IBD)
NCT02622139 ·Status: COMPLETED ·Phase: NA
-
Responsiveness of Endoscopic Evaluation in UC
NCT01960439 ·Status: COMPLETED
-
Anti-tumor Necrosis Factor in Patients With Ulcerative Colitis in Clinical Remission: to Continue or Not?
NCT03011268 ·Status: COMPLETED ·Phase: NA
-
Web-based Monitoring in Children and Adolescents With Inflammatory Bowel Disease
NCT01860651 ·Status: COMPLETED ·Phase: NA
-
Determination of the Aetiologies of Acute Colitis and Early Identification of Patients Requiring Diagnostic Colonoscopy
NCT02709213 ·Status: COMPLETED
-
Autologous Ex Vivo Expanded Regulatory T Cells in Ulcerative Colitis
NCT04691232 ·Status: COMPLETED ·Phase: PHASE1
-
Biomarkers in Inflammatory Bowel Diseases
NCT02612103 ·Status: COMPLETED
-
Autonomic and Cytokines Profiles of Patients With Ulcerative Proctitis
NCT03259659 ·Status: TERMINATED
-
Boosting Biologics in UC
NCT04241029 ·Status: COMPLETED ·Phase: NA
-
Ulcerative Colitis and Vitamin D Supplementation
NCT01846026 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
A Study to Learn About the Effectiveness of Etrasimod in People With Ulcerative Colitis
NCT06294925 ·Status: RECRUITING